丙肝治疗-昨天，明天和…

Q4 Medicine

Medizinische Monatsschrift fur Pharmazeuten Pub Date : 2017-04-01

Christof Weitzel

{"title":"丙肝治疗-昨天，明天和…","authors":"Christof Weitzel","doi":"","DOIUrl":null,"url":null,"abstract":"During the last years, treatment of chronic hepatitis C virus infection (HCV) was characterized by the development of new therapeutic agents and their combined use. By now the problem of treating HCV seems to be largely solved. The broad range of available therapeutics has the potential to enable a complete cure of this liver disease, which is associated with many complications, thus providing also economic benefits.","PeriodicalId":18540,"journal":{"name":"Medizinische Monatsschrift fur Pharmazeuten","volume":"40 4","pages":"147-50"},"PeriodicalIF":0.0000,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hepatitis C treatment – yesterday, tomorrow and …\",\"authors\":\"Christof Weitzel\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"During the last years, treatment of chronic hepatitis C virus infection (HCV) was characterized by the development of new therapeutic agents and their combined use. By now the problem of treating HCV seems to be largely solved. The broad range of available therapeutics has the potential to enable a complete cure of this liver disease, which is associated with many complications, thus providing also economic benefits.\",\"PeriodicalId\":18540,\"journal\":{\"name\":\"Medizinische Monatsschrift fur Pharmazeuten\",\"volume\":\"40 4\",\"pages\":\"147-50\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medizinische Monatsschrift fur Pharmazeuten\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medizinische Monatsschrift fur Pharmazeuten","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在过去的几年里，慢性丙型肝炎病毒感染(HCV)的治疗特点是开发新的治疗药物和它们的联合使用。到目前为止，治疗丙型肝炎病毒的问题似乎已基本解决。广泛的可用治疗方法有可能完全治愈这种与许多并发症相关的肝脏疾病，从而也提供了经济效益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Hepatitis C treatment – yesterday, tomorrow and …

During the last years, treatment of chronic hepatitis C virus infection (HCV) was characterized by the development of new therapeutic agents and their combined use. By now the problem of treating HCV seems to be largely solved. The broad range of available therapeutics has the potential to enable a complete cure of this liver disease, which is associated with many complications, thus providing also economic benefits.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Medizinische Monatsschrift fur Pharmazeuten Medicine-Pharmacology (medical)

CiteScore

0.10

自引率

0.00%

发文量

期刊介绍： •Übersichtsbeiträge zum Beispiel zur Anatomie, Physiologie und Pathophysiologie, zur Pharmakologie einer Substanz- oder Indikationsgruppe, zur Behandlung eines Krankheitsbilds •Fallberichte: der klinisch-pharmazeutische Fall •Pharmakologie aktuell: Neue Therapieprinzipien, neue Wirkungsmechanismen, neue Substanzen werden kurz und verständlich vorgestellt •Ernährungsforum: Fundierte Informationen zur Ernährung und zu Diätformen •Fragen aus der Praxis: Experten beantworten Leseranfragen •Editorial: Kommentare zu pharmazeutischen Themen •Nachrichten aus der medizinischen Forschung mit Neuigkeiten zu Diagnostik und Therapie